Clinical Trials Logo

Clinical Trial Summary

OPTIMAS is a large, phase IV, prospective, partially blinded randomised controlled trial of early (within ≤4 days [96hrs]) or standard (between day 7 and day 14 after stroke onset) initiation of anticoagulation after stroke in patients with atrial fibrillation (AF), using any licensed dose of a direct oral anticoagulant (DOAC). The trial will use a non-inferiority gatekeeper approach to test for non-inferiority of early anticoagulation followed by a test for superiority, if non-inferiority is established.


Clinical Trial Description

Current guidelines do not provide clear recommendations on the timing of OAC after acute AF-related stroke. Current UK guidelines for anticoagulation state that "delay for an arbitrary 2-week period is recommended" for "disabling" stroke and that anticoagulation can be started "no later than 14 days" for other strokes, at the prescriber's discretion.

OPTIMAS will investigate whether early initiation of DOAC treatment, within 4 days (96hrs) of onset, in patients with acute ischaemic stroke and AF is as effective as, or better than, standard initiation of DOAC treatment, no sooner than day 7 (>144hrs) and no later than day 14 (<336hrs) after onset, in preventing recurrent ischaemic stroke, systemic embolism and symptomatic intracranial haemorrhage (sICH)? Participants will be randomised 1:1 to the intervention or control. The exact timing of initiating treatment within each group is at the discretion of the treating clinician. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03759938
Study type Interventional
Source University College, London
Contact Macey Murray, PhD
Phone +44 20 3549 5013
Email ctu.optimas@ucl.ac.uk
Status Not yet recruiting
Phase Phase 4
Start date February 1, 2019
Completion date September 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT03313167 - Screening for Atrial Fibrillation (AF)-Potential Patients to Increase AF Detection Rate
Recruiting NCT03593486 - Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation N/A
Enrolling by invitation NCT03259373 - IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation N/A
Completed NCT02878213 - DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness N/A
Active, not recruiting NCT03765242 - Evaluation of Safety and Effectiveness on Oral Anticoagulants
Not yet recruiting NCT03455673 - Exclusion of Intra-atrial Thrombus Before Catheter Ablation
Not yet recruiting NCT03243175 - Avoiding Anticoagulation After IntraCerebral Haemorrhage Phase 3
Not yet recruiting NCT03503812 - Mitigating the Health Effects of Desert Dust Storms Using Exposure-Reduction Approaches N/A
Not yet recruiting NCT02808260 - Predicting Development of SCAF in Device Patients
Not yet recruiting NCT03620656 - The Validation of the FibriCheck Application for the Detection of Atrial Fibrillation
Not yet recruiting NCT03645564 - Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department N/A
Recruiting NCT02916550 - Breathing Intervention for Cardiac Anxiety N/A
Recruiting NCT02923414 - Comparison of High Versus Escalating Shocks in Cardioverting Atrial Fibrillation N/A
Recruiting NCT02982434 - The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation Phase 2
Recruiting NCT02892578 - Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home N/A
Recruiting NCT02914860 - Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology Phase 1/Phase 2
Recruiting NCT02896595 - General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation N/A
Enrolling by invitation NCT02905032 - SDM for Stroke Prevention in Atrial Fibrillation N/A
Not yet recruiting NCT02817815 - Atrial Fibrillation and Characterization of Blood Platelet N/A